In ovarian cancer, the IRE1α/XBP1 axis was shown to cripple T-cell metabolism and that T cells lacking XBP1 have superior antitumor immunity, delayed malignant progression, and increased overall survival [67]. This evidence concerns the gene ERN1 and ovarian cancer.